Skip to main content
Erschienen in: Clinical and Translational Oncology 12/2018

15.05.2018 | Research Article

Influence of age on variation in patterns of care in patients with rectal cancer in Catalonia (Spain)

verfasst von: R. Vernet, J. M. Borras, L. Aliste, M. Antonio, A. Guarga, P. Manchon-Walsh

Erschienen in: Clinical and Translational Oncology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Population ageing is a relevant concern in people diagnosed with rectal cancer. This study evaluates the adherence to clinical practice guidelines (CPGs) and patient outcomes in rectal cancer, with a particular focus on variation according to age.

Methods

This is a multicentre retrospective cohort study of all patients surgically treated for the first time for primary rectal cancer with curative intent in public hospitals in Catalonia during two study periods: first, with data from 2005 to 2007, and then with data from 2011 to 2012. We obtained the study data through a comprehensive review of patients’ clinical records. Information on diagnosis, treatment and follow-up was collected and then compared with the relevant CPGs. We then performed a descriptive analysis of the categorical variables followed by a univariate and multivariate logistic regression analysis to calculate the odds ratio. Finally, we calculated the recurrence and death rates per person-year at 2 years’ follow-up.

Results

In total, 3770 people were included in this study. The participants aged 70 and under were more likely to receive neoadjuvant therapy than those aged over 80 (2005/2007, 63 vs 17.4% p < 0.001; 2011/2012, 72 vs 41.1% p < 0.001); however, in the second study period there was less imbalance between the two groups in this regard, showing improved administration of neoadjuvant therapy in the elderly. The quality of surgery was suboptimal in a larger proportion of the elderly population, and the choice of surgical technique was dependent to some extent on the age of the participant. Recurrence and survival rates were significantly better in the second study period.

Conclusions

Compared to younger patients, the most elderly were less likely to receive the recommended adjuvant treatment, laparoscopy and total mesorectal excision. However, we observed improved adherence to the recommended treatment regimen in the most elderly participants, resulting in decreased recurrence and increased survival rates in this population.
Literatur
1.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359–86.CrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:359–86.CrossRef
2.
Zurück zum Zitat Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRef Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–403.CrossRef
3.
Zurück zum Zitat Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374(9696):1196–208.CrossRef Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374(9696):1196–208.CrossRef
4.
Zurück zum Zitat National Comprehensive Cancer Network. NCCN (2016) Clinical Practice Guidelines in Oncology: rectal cancer V.1.2016 [R]. NCCN. National Comprehensive Cancer Network. NCCN (2016) Clinical Practice Guidelines in Oncology: rectal cancer V.1.2016 [R]. NCCN.
5.
Zurück zum Zitat van de Velde JH, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, et al. EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer. 2014;50(1):1.e1–34.CrossRef van de Velde JH, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, et al. EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer. 2014;50(1):1.e1–34.CrossRef
6.
Zurück zum Zitat Manchon-Walsh P, Borras JM, Ferro T, Espinas JA. Colorectal Cancer Oncoguia Group. Colorectal Cancer Oncog Clin Transl Oncol. 2010;12(3):188–210. Manchon-Walsh P, Borras JM, Ferro T, Espinas JA. Colorectal Cancer Oncoguia Group. Colorectal Cancer Oncog Clin Transl Oncol. 2010;12(3):188–210.
7.
Zurück zum Zitat Schiffmann L, Wedermann N, Gock M, Prall F, Klautke G, Fietkau R, et al. Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications. BMC Surg. 2013;13:43.CrossRef Schiffmann L, Wedermann N, Gock M, Prall F, Klautke G, Fietkau R, et al. Intensified neoadjuvant radiochemotherapy for rectal cancer enhances surgical complications. BMC Surg. 2013;13:43.CrossRef
8.
Zurück zum Zitat Pallis AG, Mouzas IA. Adjuvant chemotherapy for colon cancer. Anticancer Res. 2006;26:4809–15.PubMed Pallis AG, Mouzas IA. Adjuvant chemotherapy for colon cancer. Anticancer Res. 2006;26:4809–15.PubMed
9.
Zurück zum Zitat Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas M. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007;246(2):215–21.CrossRef Chang GJ, Skibber JM, Feig BW, Rodriguez-Bigas M. Are we undertreating rectal cancer in the elderly? An epidemiologic study. Ann Surg. 2007;246(2):215–21.CrossRef
10.
Zurück zum Zitat Manchon-Walsh P, Borras JM, Espinas JA, Aliste L. Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action. Eur J Surg Oncol. 2011;37(4):325–33.CrossRef Manchon-Walsh P, Borras JM, Espinas JA, Aliste L. Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action. Eur J Surg Oncol. 2011;37(4):325–33.CrossRef
11.
Zurück zum Zitat Ribes J, Galvez J, Melia A, Cleries R, Messeguer X, Bosch FX. Automatization of a hospital-based tumor registry. Gac Sanit. 2005;19(3):221–8.CrossRef Ribes J, Galvez J, Melia A, Cleries R, Messeguer X, Bosch FX. Automatization of a hospital-based tumor registry. Gac Sanit. 2005;19(3):221–8.CrossRef
12.
Zurück zum Zitat Lemmens VE, Janssen-Heijnen ML, Houterman S, Verheij KD, Martijn H, van de Poll-Franse L, et al. Which comorbid conditions predict complications after surgery for colorectal cancer? World J Surg. 2007;31(1):192–9.CrossRef Lemmens VE, Janssen-Heijnen ML, Houterman S, Verheij KD, Martijn H, van de Poll-Franse L, et al. Which comorbid conditions predict complications after surgery for colorectal cancer? World J Surg. 2007;31(1):192–9.CrossRef
13.
Zurück zum Zitat Vulto AJ, Lemmens VE, Louwman MW, Janssen-Heijnen ML, Poortmans PH, Lybeert ML, et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands. 1995–2002. Cancer. 2006;106(12):2734–42.CrossRef Vulto AJ, Lemmens VE, Louwman MW, Janssen-Heijnen ML, Poortmans PH, Lybeert ML, et al. The influence of age and comorbidity on receiving radiotherapy as part of primary treatment for cancer in South Netherlands. 1995–2002. Cancer. 2006;106(12):2734–42.CrossRef
14.
Zurück zum Zitat Wedding U, Roehrig B, Klippstein A, Steiner P, Schaeffer T, Pientka L, et al. Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness rating scale. Crit Rev Oncol Hematol. 2007;61:269–76.CrossRef Wedding U, Roehrig B, Klippstein A, Steiner P, Schaeffer T, Pientka L, et al. Comorbidity in patients with cancer: prevalence and severity measured by cumulative illness rating scale. Crit Rev Oncol Hematol. 2007;61:269–76.CrossRef
15.
Zurück zum Zitat Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results—medicare. J Clin Oncol. 2001;19:3712–8.CrossRef Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results—medicare. J Clin Oncol. 2001;19:3712–8.CrossRef
16.
Zurück zum Zitat Ayanian JZ, Zaslavsky AM, Fuchs CS, Guadagnoli E, Creech CM, Cress RD, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003;21:1293–300.CrossRef Ayanian JZ, Zaslavsky AM, Fuchs CS, Guadagnoli E, Creech CM, Cress RD, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003;21:1293–300.CrossRef
17.
Zurück zum Zitat Mor V, Masterson-Allen S, Goldberg RJ, Cummings FJ, Glicksman AS, Fretwell MD. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc. 1985;33(9):585–9.CrossRef Mor V, Masterson-Allen S, Goldberg RJ, Cummings FJ, Glicksman AS, Fretwell MD. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc. 1985;33(9):585–9.CrossRef
18.
Zurück zum Zitat Jung B, Pahlman L, Johansson R, Nilson E. Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish Rectal Cancer Registry 1995–2004. BMC Cancer. 2009;9:68.CrossRef Jung B, Pahlman L, Johansson R, Nilson E. Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish Rectal Cancer Registry 1995–2004. BMC Cancer. 2009;9:68.CrossRef
19.
Zurück zum Zitat Shahir MA, Lemmens VE, Van de Poll-Franse LV, Voogd AC, Martijn H, Janssen-Heijnen ML. Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer. 2006;42:3015–21.CrossRef Shahir MA, Lemmens VE, Van de Poll-Franse LV, Voogd AC, Martijn H, Janssen-Heijnen ML. Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer. 2006;42:3015–21.CrossRef
20.
Zurück zum Zitat Cai X, Wu H, Peng J, Zhu J, Cai S, Cai G, et al. Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older. Radiat Oncol. 2013;8:86.CrossRef Cai X, Wu H, Peng J, Zhu J, Cai S, Cai G, et al. Tolerability and outcomes of radiotherapy or chemoradiotherapy for rectal cancer in elderly patients aged 70 years and older. Radiat Oncol. 2013;8:86.CrossRef
21.
Zurück zum Zitat Guimas V, Boustani J, Schipman B, Lescut N, Puyraveau M, Bosset JF, et al. Preoperative chemoradiotherapy for rectal cancer in patients aged 75 years and older: acute toxicity, compliance with treatment, and early results. Drugs Aging. 2016;33:419–25.CrossRef Guimas V, Boustani J, Schipman B, Lescut N, Puyraveau M, Bosset JF, et al. Preoperative chemoradiotherapy for rectal cancer in patients aged 75 years and older: acute toxicity, compliance with treatment, and early results. Drugs Aging. 2016;33:419–25.CrossRef
22.
Zurück zum Zitat van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575–82.CrossRef van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011;12(6):575–82.CrossRef
23.
Zurück zum Zitat Pettersson D, Holm T, Iversen H, Blomqvist L, Grimelius B, Martling A. Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg. 2012;99(4):577–83.CrossRef Pettersson D, Holm T, Iversen H, Blomqvist L, Grimelius B, Martling A. Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg. 2012;99(4):577–83.CrossRef
24.
Zurück zum Zitat Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer: a multicentre, randomised trial. Lancet. 2009;373:811–20.CrossRef Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer: a multicentre, randomised trial. Lancet. 2009;373:811–20.CrossRef
25.
Zurück zum Zitat Neugut AI, Fleischauer AT, Sundarajan V, Mitra N, Heitjan DF, Jacobson JS, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002;20:2643–50.CrossRef Neugut AI, Fleischauer AT, Sundarajan V, Mitra N, Heitjan DF, Jacobson JS, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol. 2002;20:2643–50.CrossRef
26.
Zurück zum Zitat Kim JH. Chemotherapy for colorectal cancer in the elderly. World J Gastroenterol. 2015;21(17):5158–66.CrossRef Kim JH. Chemotherapy for colorectal cancer in the elderly. World J Gastroenterol. 2015;21(17):5158–66.CrossRef
27.
Zurück zum Zitat Puts M, Tapscott B, Fitch M, Howell D, Monette J, Wan-Chow-Wah D, et al. A systematic review of factors influencing older adults hypothetical treatment decisions. Oncol Hemat Rev. 2015;11(1):19–33. Puts M, Tapscott B, Fitch M, Howell D, Monette J, Wan-Chow-Wah D, et al. A systematic review of factors influencing older adults hypothetical treatment decisions. Oncol Hemat Rev. 2015;11(1):19–33.
28.
Zurück zum Zitat Antonio M, Saldaña J, Carmona-Bayonas A. Geriatric assessment predicts survival and competing mortality in elderly patients with early colorectal cancer. Can it help in adjuvant therapy decision-making? Oncologist. 2017;22:1–10.CrossRef Antonio M, Saldaña J, Carmona-Bayonas A. Geriatric assessment predicts survival and competing mortality in elderly patients with early colorectal cancer. Can it help in adjuvant therapy decision-making? Oncologist. 2017;22:1–10.CrossRef
29.
Zurück zum Zitat Prades J, Borras JM. Shifting sands: adapting the multidisciplinary team model to technological and organizational innovations in cancer care. Future Oncol. 2014;10(13):1995–8.CrossRef Prades J, Borras JM. Shifting sands: adapting the multidisciplinary team model to technological and organizational innovations in cancer care. Future Oncol. 2014;10(13):1995–8.CrossRef
30.
Zurück zum Zitat Wibe A, Moller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, for The Norwegian Rectal Cancer Group, et al. A national strategic change in the treatment policy for rectal cancer implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002;45:857–66.CrossRef Wibe A, Moller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, for The Norwegian Rectal Cancer Group, et al. A national strategic change in the treatment policy for rectal cancer implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002;45:857–66.CrossRef
31.
Zurück zum Zitat Van Gijn W, Krijnen P, Lemmens VE, den Dulk M, Putter H, van de Velde CJ. Quality assurance in rectal cancer treatment in the Netherlands: a catch up compared to colon cancer treatment. Eur J Surg Oncol. 2010;36(4):340–4.CrossRef Van Gijn W, Krijnen P, Lemmens VE, den Dulk M, Putter H, van de Velde CJ. Quality assurance in rectal cancer treatment in the Netherlands: a catch up compared to colon cancer treatment. Eur J Surg Oncol. 2010;36(4):340–4.CrossRef
32.
Zurück zum Zitat Akiyoshi T, Kuroyanagi H, Oya M, Konishi T, Fukuda M, et al. Short-term outcomes of laparoscopic rectal surgery for primary rectal cancer in elderly patients: is it safe and beneficial? J Gastrointest Surg. 2009;13:1614–8.CrossRef Akiyoshi T, Kuroyanagi H, Oya M, Konishi T, Fukuda M, et al. Short-term outcomes of laparoscopic rectal surgery for primary rectal cancer in elderly patients: is it safe and beneficial? J Gastrointest Surg. 2009;13:1614–8.CrossRef
33.
Zurück zum Zitat Roscio F, Bertoglio C, De Luca A, Frigerio A, Galli F, Scandroglio I. outcomes of laparoscopic surgery for colorectal cancer in elderly patients. JSLS. 2011;15:315–21.CrossRef Roscio F, Bertoglio C, De Luca A, Frigerio A, Galli F, Scandroglio I. outcomes of laparoscopic surgery for colorectal cancer in elderly patients. JSLS. 2011;15:315–21.CrossRef
34.
Zurück zum Zitat Kolfschoten NE, van Leersum NJ, Gooiker GA, Marang van de Mheen PJ, Eddes EH, Kievit J, et al. Sucessful and safe introduction of laparoscopic colorectal cáncer surgery in Dutch hospitals. Ann Surg. 2013;257:916–21.CrossRef Kolfschoten NE, van Leersum NJ, Gooiker GA, Marang van de Mheen PJ, Eddes EH, Kievit J, et al. Sucessful and safe introduction of laparoscopic colorectal cáncer surgery in Dutch hospitals. Ann Surg. 2013;257:916–21.CrossRef
35.
Zurück zum Zitat Gatta G, Capocaccia R, Sant M, Bell CM, Coeberg JW, Damhuis RA, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut. 2000;47:533–8.CrossRef Gatta G, Capocaccia R, Sant M, Bell CM, Coeberg JW, Damhuis RA, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut. 2000;47:533–8.CrossRef
36.
Zurück zum Zitat Lemmens VE, Verheij CDGW, Janssen-Heijnen MLG, Rutten HJT. Coeberg JWW, on behalf of the Gastro-Intestinal Cancer Study Group. Mixed adherence to clinical practice guidelines for colorectal cancer in the Southern Netherlands in 2002. EJSO. 2006;321:68–73. Lemmens VE, Verheij CDGW, Janssen-Heijnen MLG, Rutten HJT. Coeberg JWW, on behalf of the Gastro-Intestinal Cancer Study Group. Mixed adherence to clinical practice guidelines for colorectal cancer in the Southern Netherlands in 2002. EJSO. 2006;321:68–73.
37.
Zurück zum Zitat van Leeuwen BL, Pahlman L, Gunnarsson U, Sjövall A, Martling A. The effect of age and gender on outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm region. Crit Rev Oncol Hematol. 2008;67:229–36.CrossRef van Leeuwen BL, Pahlman L, Gunnarsson U, Sjövall A, Martling A. The effect of age and gender on outcome after treatment for colon carcinoma. A population-based study in the Uppsala and Stockholm region. Crit Rev Oncol Hematol. 2008;67:229–36.CrossRef
38.
Zurück zum Zitat Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312(25):1604–8.CrossRef Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985;312(25):1604–8.CrossRef
Metadaten
Titel
Influence of age on variation in patterns of care in patients with rectal cancer in Catalonia (Spain)
verfasst von
R. Vernet
J. M. Borras
L. Aliste
M. Antonio
A. Guarga
P. Manchon-Walsh
Publikationsdatum
15.05.2018
Verlag
Springer International Publishing
Erschienen in
Clinical and Translational Oncology / Ausgabe 12/2018
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-018-1882-8

Weitere Artikel der Ausgabe 12/2018

Clinical and Translational Oncology 12/2018 Zur Ausgabe

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.